Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Clinical-genetic care of BRCA-mutation carrier women: prevention, diagnosis and therapy].

Orvosi hetilap - 5 Jun 2011

Nagy Zsolt, Csanád Mónika, Tóth Katalin, Máté Szabolcs, Joó József Gábor

Abstract excerpt

Predictive genetics opens a considerable perspective in the diagnostics as well as the treatment of breast and ovarian cancer. Current recommendations and guidelines for the management of BRCA 1 and BRCA 2 mutation carriers are not based on controlled randomized trials, but on expert opinions. The existing options of prevention, early diagnosis and treatment must be clearly interpreted to the patient. In the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Early Detection of Cancer
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Genetic Counseling

Share to Heterozygote

Share to Ovarian Neoplasms

Share to Primary Prevention

Source

Identifiers

PMID: 21592951
DOI: 10.1556/OH.2011.29131

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Clinical-genetic care of BRCA-mutation carrier women: prevention, diagnosis and therapy].PMID 21592951Read ↗

[Hereditary breast and ovarian cancer - indications for genetic testing, counseling and options for mutation carriers].Semantic proximity Read ↗

[Who must be referred for genetic counseling?]Semantic proximity Read ↗

[Peculiarities of diagnosis, treatment and prevention of hereditary cancer of the breast and ovary. Clinical and genetic screening among BRCA1/2 mutation carriers and individuals with high family risk of cancer].Semantic proximity Read ↗

[BRCA1- and BRCA2 mutations: Clinical management of patients with hereditary breast and ovarian cancer].Semantic proximity Read ↗

[Gynecological Care and Prevention of Gynecological Malignancies in BRCA1 and BRCA2 Mutation Carriers].Semantic proximity Read ↗

[INSERM-FNCLCC collective expertise. Recommendations for medical management of women with genetic risk of developing breast and/or ovarian cancer].Semantic proximity Read ↗

[Medical management of women with inherited predisposition to breast cancer: indications and procedures for mammographic screening].Semantic proximity Read ↗

[INSERM-FNCLCC collective expert's report. Recommendations for management of women having a genetic risk of developing breast and/or ovarian cancer. National Federation of Centers of the Fight Against Cancer].Semantic proximity Read ↗

BRCA1 and BRCA2: the genetic testing and the current management options for mutation carriers.Semantic proximity Read ↗

[Management of families at high risk for hereditary breast-ovarian cancers: the endocrinologist's point of view].Semantic proximity Read ↗

[Clinical counseling and care of women with genetic predisposition to breast and ovarian carcinoma].Semantic proximity Read ↗

[Predictive genetic testing for hereditary breast cancer and hereditary nonpolyposis colorectal cancer].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.